Anti-GD2 4th Generation CART Cells Targeting Refractory and/or Recurrent Neuroblastoma
NCT02765243
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Neuroblastoma
Effects of Immunotherapy
Interventions
BIOLOGICAL:
Anti-GD2 CART
Sponsor
Zhujiang Hospital